v3.26.3
Segment and Geographic Information
 9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Segment and Geographic Information Segment and Geographic Information
The Company operates in one segment: pharmaceutical products. Its chief operating decision maker is the Chief Executive Officer, who makes operating decisions, assesses performance and allocates resources on a consolidated basis.
The primary measure of segment profitability for the Company’s operating segment is considered to be consolidated net income. Significant segment expenses reviewed by the CODM on a regular basis included within net income include cost of product sales, research and development expenses and selling, general and administrative expenses which are separately presented on the Company’s consolidated statements of operations. Other segment items within net income include interest income, interest expense, other income (expense), net and income tax expense.
The Company’s long-lived assets are primarily located in the U.S. and China.
Net product revenues by geographic area are based upon the location of the customer, and other revenue is recorded in the jurisdiction in which the related income is expected to be sourced from. Total revenues by geographic area are presented as follows:
Three Months EndedNine Months Ended
September 30,September 30,
2026202520262025
$$$$
U.S. - total revenue1,027,915 754,856 2,724,375 2,016,494 
Product revenue1,013,241 742,687 2,677,470 1,991,430 
Other revenue14,674 12,169 46,905 25,064 
China - total revenue536,365 439,885 1,514,360 1,272,401 
Product revenue527,351 434,783 1,492,247 1,259,947 
Other revenue9,014 5,102 22,113 12,454 
Europe - total revenue239,555 166,576 642,306 437,514 
Product revenue234,180 166,576 633,904 435,788 
Other revenue5,375 — 8,402 1,726 
Rest of world - total revenue85,980 50,967 227,283 118,454 
Product revenue80,285 50,967 218,559 118,454 
Other revenue5,695 — 8,724 — 
Total Revenue1,889,815 1,412,284 5,108,324 3,844,863